Related Experiment Video
Updated: Jun 11, 2025

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
Aberrant NSUN2-mediated m5C modification of exosomal LncRNA MALAT1 induced RANKL-mediated bone destruction in
Manya Yu1, Zhiguo Cai2, Jie Zhang3
1The First School of Clinical Medicine, Shandong University of Traditional Chinese Medicine, No. 16369 Jingshi Road, Jinan, 250014, China.
Abstract:
The impact of exosome-mediated crosstalk between multiple myeloma (MM) cells and osteoclasts (OCs) on bone lesions remains to be investigated. Here, we identified NSUN2 and YBX1-mediated m5C modifications upregulated LncRNA MALAT1 expression in MM cells, which could be transported to OCs via exosomes and promote bone lesions. Methodologically, RNA-seq was carried out to detect the cargoes of exosomes. TRAP staining and WB were used to evaluate osteoclastogenesis in vitro. Micro-CT and bone histomorphometric analyses were performed to identify bone destruction in vivo. RNA pull-down, RIP, MeRIP, and luciferase reporter assays were used to test the interactions between molecules. The clinical features of MALAT1, NSUN2 and YBX1 were verified through public datasets and clinicopathological data analyses. Mechanistically, MALAT1 was the highest expressed lncRNA in U266 exosomes and could be transported to RAW264.7 cells. MALAT1 could enhance the differentiation of RAW264.7 cells into OCs by stimulating RANKL expression and its downstream AKT and MAPKs signaling pathways via a ceRNA mechanism. Additionally, MALAT1 could be modified by NSUN2, an m5C methyltransferase, which in turn stabilized MALAT1 through the "reader" YBX1. Clinical studies indicated a notable positive correlation between MALAT1, NSUN2, YBX1 levels and bone destruction features, as well as with RANKL expression.
Insights
Exosomes from multiple myeloma cells transfer MALAT1 to osteoclasts, promoting bone lesions. This transfer is mediated by NSUN2 and YBX1, highlighting a novel therapeutic target for bone destruction in multiple myeloma.
Area of Science:
- Molecular Biology
- Oncology
- Bone Biology
Background:
- The role of exosome-mediated communication between multiple myeloma (MM) cells and osteoclasts (OCs) in the development of bone lesions is not fully understood.
- Understanding the molecular mechanisms driving MM-induced bone destruction is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the impact of exosome-mediated crosstalk between MM cells and OCs on bone lesions.
- To elucidate the molecular players and mechanisms involved in MM cell-induced osteoclastogenesis and bone destruction.
Main Methods:
- Exosome cargo analysis using RNA-sequencing.
- In vitro osteoclastogenesis assays (TRAP staining, Western blot).
- In vivo bone destruction assessment (Micro-CT, bone histomorphometry).
- Molecular interaction studies (RNA pull-down, RIP, MeRIP, luciferase reporter assays).
- Clinical data analysis of MALAT1, NSUN2, and YBX1 expression.
Main Results:
- NSUN2 and YBX1-mediated m5C modifications upregulated LncRNA MALAT1 in MM cells, which was transported to OCs via exosomes.
- Exosomal MALAT1 promoted osteoclast differentiation and bone destruction by enhancing RANKL expression and activating AKT/MAPKs signaling pathways via a ceRNA mechanism.
- NSUN2 methyltransferase stabilized MALAT1 through the YBX1 reader protein.
- Clinical data showed a positive correlation between MALAT1, NSUN2, YBX1 levels, bone destruction, and RANKL expression.
Conclusions:
- Exosomal MALAT1, regulated by NSUN2 and YBX1, plays a critical role in promoting osteoclastogenesis and bone lesions in multiple myeloma.
- The NSUN2/MALAT1/YBX1 axis represents a potential therapeutic target for mitigating bone destruction in MM patients.
Related Concept Videos
Abnormal Proliferation
lncRNA - Long Non-coding RNAs
Nuclear Export of mRNA
RNA Splicing
MicroRNAs
The Nucleolus

